Daily Archives: May 26, 2020

Businessman SuhendraHadikuntono to sell companies to stem COVID-19

Jakarta Businessman-cum-intelligence observer SuhendraHadikuntono plans to sell several of his companies, clocking a turnover of hundreds of billions of rupiah, to assist the government in the fight against the COVID-19 pandemic.

“In my viewpoint, if other people no longer need us, then we have actually died. What the nation needs now is not discourse but concrete action to help our fellow citizens,” he noted in a written statement released on Monday night.

The companies that Hadikuntono intends to sell are engaged in property and mining as well as secure parking businesses, among others.

The companies, under the aegis of Indo Sarana Group, are operating in Jakarta and other cities in the country, including Bandung and Cirebon in West Java, Pekalongan and Semarang in Central Java, Surabaya in East Java, and Yogyakarta.

The companies currently employ thousands of workers.

Hadikuntono has vowed to channel proceeds from the sale of the companies to purchase personal protective equipment (PPE) for medical workers on the forefront in the battle against the spread of coronavirus.

“If we talk about the world, the talk will never end. What we need now is sacrifice to contain the pandemic since nobody knows when it will end. We do what we can do. The country now calls upon us,” he emphasized.

Hadikuntono remarked that the sale of the companies will run transparently, and all taxes arising from this will be paid to the state treasury.

Hadikuntono is also known to have broad networks with various circles at home and abroad. In fact, Thailand once requested him to act as an intermediary in the conflict in South Thailand.

Moreover, he held the post of chief of the Indonesia-Vietnam Human Rights Violation Settlement that freed 150 Vietnamese detained on Anambas Island for allegedly violating the Indonesian waters.


Source: Antara News

Flooding forced 605 Samarinda residents to evacuate


Samarinda, E Kalimantan Floods submerged several parts of Samarinda, the capital of East Kalimantan Province, in the past three days, compelling 605 residents to evacuate to higher ground, the local disaster mitigation office stated.

“On the basis of preliminary data, the 605 affected people that took refuge are all residents of Sungai Pinang Sub-district. However, several others may not have been recorded,” acting chief of the Samarinda City Disaster Mitigation Office (BPBD) Hendra A. H. noted here on Tuesday.

According to the BPBD, flooding has inundated 13,157 homes in four sub-districts in Samarinda.

A total of 30,895 residents in the four sub-districts were affected by the flooding.

North Samarinda Sub-district was the worst-affected by the flooding, with 1,671 homes inundated and 13,896 residents impacted by it, he pointed out.


Source: Antara News

Jakarta to quarantine, return entrants unable to present entry permit

Jakarta Operator of the PuloGebang Integrated Bus Terminal in East Jakarta will quarantine or return to the origin cities those entering the capital city without the Jakarta Exit and Entry Permit (SIKM).

“Without the Jakarta Exit and Entry Permit (SIKM), they will be returned to their cities of origin or quarantined at a location determined by the (COVID-19) task force,” head of the PuloGebang integrated terminal Bernard Pasaribu stated here on Tuesday.

Pasaribu explained that people, who will enter or exit the capital city, are required to apply for SIKM in accordance with Governor Regulation No. 47 of 2020 on restriction on exit from and entry to Jakarta to stem the spread of COVID-19.

A joint team of the Indonesian Military (TNI), police, Transportation Office, and the municipal police (Satpol PP) will check all passengers of buses that pass the check posts.

“Security personnel have guarded the entry points. Those, who managed to pass the check posts and reach the bus terminal, will be returned to their cities of origin if they are unable to present the SKIM,” he stated.

At least 193 people arrived at the PuloGebang bus terminal on May 9-24 when it resumed operations after being closed owing to the COVID-19 pandemic.


Source: Antara News

Jakarta’s COVID-19 curve has begun flattening: Task Force Chief


Jakarta The curve of COVID-19 infections in Jakarta has begun to flatten based on the risk map, chief of the expert team of the Task Force for Acceleration of COVID-19 Handling Prof. WikuAdisasmito stated.

“The curve has begun to flatten in Jakarta. However, if the returning (Eid-al-Fitr) holidaymakers are not prevented, then they will lead to a second wave (of COVID-19 cases),” he noted during an online press conference in Jakarta on Tuesday.

People, who will enter or exit the capital city, are required to apply for an Exit and Entry Permit (SIKM) in accordance with Governor Regulation No. 47 of 2020 on restriction on exit from and entry to Jakarta to stem the spread of COVID-19.

If they do not secure an SIKM, they will be ordered to return to their cities of origin or quarantined at a location determined by the COVID-19 task force.

Adisasmito pointed to a rise in the number of confirmed coronavirus cases in East Java Province.

He highlighted the public’s full participation in curbing the trend of COVID-19 cases in Jakarta and preventing the rising number of COVID-19 cases in East Java.

According to the World Health Organization (WHO), a region can conduct social and economic activities in the midst of the COVID-19 pandemic if it meets three main aspects, he noted.

“The indicators of public health are based on three main aspects, specifically epidemiology picture, public health surveillance, and health service,” he revealed.

The epidemiology of a region will be viewed as good if the number of COVID-19 positive cases, patients under treatment, people under surveillance, and deaths dropped to at least 50 percent in the past couple of weeks after the last peak, he expounded.

In addition, public health surveillance should be intensified.

“The number of samples tested at laboratories must increase while concurrently the number of positive cases must decline,” he stated.

The health service encompasses the number of beds and personal protective equipment available to handle COVID-19 patients, he remarked.


Source: Antara News

Philips launches next generation wearable biosensor for early patient deterioration detection, including clinical surveillance for COVID-19

May 26, 2020

  • Wireless wearable biosensor (Philips Biosensor BX100) receives 510(k) clearance from the FDA and CE mark to help monitor COVID-19 patients in hospital, with first install at OLVG Hospital in the Netherlands
  • Further enhances Philips portfolio of devices, software and services for identifying patients at risk for deterioration while limiting exposure to help improve staff and patient safety and preserve valuable personal protective equipment

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its wearable biosensor (Philips Biosensor BX100) to help manage confirmed and suspected COVID-19 patients in the hospital. The next generation wireless wearable biosensor enhances clinical surveillance in the Philips patient deterioration detection solution to help clinicians detect risk so they can intervene earlier and help improve care for patients in lower acuity care areas. The solution has already received CE mark, and is currently in use with the first install at the OLVG Hospital in the Netherlands to help manage the triage and clinical surveillance of COVID-19 patients.

The Philips Biosensor BX100 is designed to address a new approach to vital signs measurements, supporting surveillance of higher acuity patients moving from intensive care units into lower acuity general care areas of a hospital.  The lightweight, disposable biosensor is a 5-day, single-use wearable patch which can be integrated with a scalable hub to monitor multiple patients across multiple rooms. Built to incorporate into existing clinical workflows for mobile viewing and notifications, the device requires no cleaning or charging. The medical-grade wireless wearable biosensor, intended for use by healthcare professionals on patients 18 years of age and older, adheres discreetly to the chest to collect, store, measure and transmit respiratory rate and heart rate every minute – the top two predictors of deterioration – as well as contextual parameters such as posture, activity level and ambulation.

OLVG, a top clinical, referral and training hospital in the Netherlands is responding to the COVID-19 emergency situation by remotely monitoring patients in isolation rooms who are diagnosed or suspected of COVID, but don’t need ventilation. To meet the hospital’s need to support COVID-19 patients in isolation, OLVG has implemented Philips patient deterioration detection solution comprised of data-driven intelligent analytics software (IntelliVue GuardianSoftware) for early warning scoring, advanced patient monitors (EarlyVue VS30), and the Philips Biosensor BX100 wearable sensors.

“During this unprecedented time of COVID-19, the Philips Biosensor BX100 helps provide rapid deployment for clinical surveillance to help decrease risk of exposure of healthcare workers while acquiring frequent patient vitals, and easing the demand for personal protective equipment (PPE),” said Peter Ziese, General Manager Monitoring and Analytics at Philips. “The biosensor is an integral component in our Patient Deterioration Detection solution which helps aid in the identification of the subtle signs of deterioration in a patient’s condition at the point of care, hours before a potential adverse event would occur.”

“With the help of this new biosensor, we can continuously and remotely monitor patients, which is especially important on the COVID-19 wards,” said Florian van der Hunnik, Chief Nursing Information Officer and team leader of the COVID-19 ward at OLVG Hospital in Amsterdam. “Because we cannot walk in and out of the patient rooms without protective gear, we welcome this innovation as it helps improve how we can do our jobs better.”

The Philips next generation wearable biosensor is part of the Philips comprehensive portfolio of solutions to address patient deterioration, supporting general care around the world with smart clinical intelligence. For more information on how Philips is addressing the Coronavirus globally, please visit the Philips centralized COVID-19 hub.

For further information, please contact:

Kathy O’Reilly
Philips Global Press Office
Tel.: +1 978 221 8919
E-mail: kathy.oreilly@philips.com
Twitter: @kathyoreilly

Pieter van Meer
Philips Benelux
Tel.: +31 6 25 2690 65
Email: pieter.de.meer@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.